Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

Canada
NITAGs
29 March 2017

NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

  1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
  2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
  3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
  4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.

ca.png
Documents to download

Related News & Events

  • WHO China
    Beijing, P.R. China
  • Kazakhstan
    NITAGs

    Voice from the field : Lyazzat Yeraliyeva

    14.11.2017

    The NITAG of Kazakhstan recently launched their website to make their recommendations available and promote the work of the members. Lyazzat Yeraliyeva, former Chair of the NITAG, now acts as the Deputy Chair.

    Read more
  • NITAGs

    Strenghtening NITAGs through the Partnership for Influenza Vaccine Introduction

    07.11.2017

    The Partnership for Influenza Vaccine Introduction (PIVI), based at The Task Force for Global Health (TFGH), is an innovative public/private program that partners with the Centers for Disease Control and Prevention (CDC), Ministries of Health, corporate partners and others to create sustainable, routine, seasonal influenza vaccination programs in low- and middle-income countries.   PIVI’s goal is to create routine, seasonal influenza vaccination programs to protect communities from the impacts of both seasonal and pandemic influenza. Working with countries’ Ministries of Health, as well as with other technical collaborators, PIVI supports capacity building for NITAGs to make evidence-based vaccine policy decision making.  These activities are coordinated with NITAG strengthening work carried out through other projects and cooperative funding agreements between countries and CDC’s Influenza and Global Immunization Divisions.  The work is also closely coordinated with NITAG focal points in WHO regional and country offices.  

    Read more